{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:46:02Z","timestamp":1789469162448,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00203-026-05214-9","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:48:49Z","timestamp":1789465729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a PapG\u2013AcmA surface-associated antigen on Lactobacillus reuteri as a vaccine strategy against uropathogenic Escherichia coli"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-8397","authenticated-orcid":false,"given":"Meisam","family":"Akrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-0402","authenticated-orcid":false,"given":"Maryam","family":"Akrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2532-5919","authenticated-orcid":false,"given":"Amirhossein","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9681-6954","authenticated-orcid":false,"given":"Parisa","family":"Haeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"5214_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18843","author":"VA Abdullatif","year":"2021","unstructured":"Abdullatif VA, Sur RL, Eshaghian E, Gaura KA, Goldman B, Panchatsharam PK et al (2021) Efficacy of probiotics as prophylaxis for urinary tract infections in premenopausal women: a systematic review and meta-analysis. Cureus. https:\/\/doi.org\/10.7759\/cureus.18843","journal-title":"Cureus"},{"issue":"8","key":"5214_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/protein\/14.8.529","volume":"14","author":"R Arai","year":"2001","unstructured":"Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T (2001) Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng 14(8):529\u2013532","journal-title":"Protein Eng"},{"issue":"5","key":"5214_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00284-026-04813-5","volume":"83","author":"M Asim","year":"2026","unstructured":"Asim M, Rizvi SA, Ahmed V, Haq QMR (2026) An update on escalating drug resistance among uropathogenic bacteria: challenges in treatment and scope for maneuver. Curr Microbiol 83(5):243","journal-title":"Curr Microbiol"},{"issue":"6","key":"5214_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1586\/erv.12.36","volume":"11","author":"AR Brumbaugh","year":"2012","unstructured":"Brumbaugh AR, Mobley HL (2012) Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 11(6):663\u2013676","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"5214_CR5","first-page":"471","volume":"16","author":"AP Cahyani","year":"2026","unstructured":"Cahyani AP, Tyasningsih W, Wibisono FJ, Effendi MH, Permatasari DA, Tang JYH et al (2026) The role of Uropathogenic Escherichia coli (UPEC) virulence genes in Urinary Tract Infection (UTI) cases in cats. J Adv Veterinary Res 16(3):471\u2013478","journal-title":"J Adv Veterinary Res"},{"issue":"10","key":"5214_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen W-C (2013) Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 65(10):1357\u20131369","journal-title":"Adv Drug Deliv Rev"},{"key":"5214_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1872554","volume":"17","author":"RS Cole","year":"2026","unstructured":"Cole RS, Silmon de Monerri NC, Lypowy J, Ponce C, Kobylarz C, Liu L et al (2026) Improving the immunogenicity of E. coli FimH via multivalent display on I53-50 nanoparticles. Front Immunol 17:1872554","journal-title":"Front Immunol"},{"issue":"10","key":"5214_CR8","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","volume":"183","author":"AM Didierlaurent","year":"2009","unstructured":"Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H et al (2009) AS04, an aluminum salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 183(10):6186\u20136197","journal-title":"J Immunol"},{"issue":"6","key":"5214_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1014299","volume":"22","author":"C Ellison","year":"2026","unstructured":"Ellison C, Cottam C, Lian ZJ, Onur T, Choudhry BA, Ong YYT et al (2026) Yad fimbriae are triggered by host cues and enhance extraintestinal pathogenic Escherichia coli tissue colonisation during bloodstream infection. PLoS Pathog 22(6):e1014299","journal-title":"PLoS Pathog"},{"issue":"9","key":"5214_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2165\/00003495-200666090-00007","volume":"66","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Betsi GI, Tokas T, Athanasiou S (2006) Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 66(9):1253\u20131261","journal-title":"Drugs"},{"issue":"5","key":"5214_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269\u2013284","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"5214_CR12","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms27104271","volume":"27","author":"AH Garc\u00eda","year":"2026","unstructured":"Garc\u00eda AH, De Sanctis JB (2026) Vaccine adjuvants and delivery systems: A comprehensive review. Int J Mol Sci 27(10):4271","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5214_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/microorganisms13040745","volume":"13","author":"JD Garc\u00eda-Garc\u00eda","year":"2025","unstructured":"Garc\u00eda-Garc\u00eda JD, Contreras-Alvarado LM, Cruz-C\u00f3rdova A, Hern\u00e1ndez-Castro R, Flores-Encarnacion M, Rivera-Guti\u00e9rrez S et al (2025) Pathogenesis and immunomodulation of urinary tract infections caused by uropathogenic Escherichia coli. Microorganisms 13(4):745","journal-title":"Microorganisms"},{"issue":"8","key":"5214_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.25122\/jml-2024-0396","volume":"18","author":"KB Gebremedhin","year":"2025","unstructured":"Gebremedhin KB, Amogne W, Alemayehu H, Bopegamage S, Eguale T (2025) The role of uropathogenic Escherichia coli virulence factors in the development of urinary tract infection. J Med Life 18(8):701","journal-title":"J Med Life"},{"issue":"3","key":"5214_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1586\/erv.12.5","volume":"11","author":"AS Ginsburg","year":"2012","unstructured":"Ginsburg AS, Nahm MH, Khambaty FM, Alderson MR (2012) Issues and challenges in the development of pneumococcal protein vaccines. Expert Rev Vaccines 11(3):279\u2013285","journal-title":"Expert Rev Vaccines"},{"key":"5214_CR16","first-page":"1","volume":"85","author":"M Guedes","year":"2026","unstructured":"Guedes M, Peters S, Joshi A, Dorn S, Rieger J, Klapproth K et al (2026) Uropathogenic Escherichia coli invade luminal prostate cells via FimH\u2013PPAP receptor binding. Nat Microbiol 85:1\u201316","journal-title":"Nat Microbiol"},{"issue":"3","key":"5214_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1574-6976.2012.00339.x","volume":"36","author":"TJ Hannan","year":"2012","unstructured":"Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ (2012) Host\u2013pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 36(3):616\u2013648","journal-title":"FEMS Microbiol Rev"},{"key":"5214_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev.micro.112408.134258","volume":"64","author":"DA Hunstad","year":"2010","unstructured":"Hunstad DA, Justice SS (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64:203\u2013221","journal-title":"Annu Rev Microbiol"},{"key":"5214_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1792758","volume":"17","author":"Z Jin","year":"2026","unstructured":"Jin Z, Zhou Z, Chen W, Xue Y, Zhang Z (2026) Decoding epithelial-immune cell crosstalk in uropathogenic Escherichia coli urinary tract infections. Front Microbiol 17:1792758","journal-title":"Front Microbiol"},{"issue":"2","key":"5214_CR20","first-page":"261","volume":"17","author":"JR Johnson","year":"2003","unstructured":"Johnson JR (2003) Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Disease Clin 17(2):261\u2013278","journal-title":"Infect Disease Clin"},{"issue":"5312","key":"5214_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1126\/science.276.5312.607","volume":"276","author":"S Langermann","year":"1997","unstructured":"Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J et al (1997) Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276(5312):607\u2013611","journal-title":"Science"},{"key":"5214_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01509","volume":"11","author":"P Loubet","year":"2020","unstructured":"Loubet P, Ranfaing J, Dinh A, Dunyach-Remy C, Bernard L, Bruy\u00e8re F et al (2020) Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol 11:515350","journal-title":"Front Microbiol"},{"issue":"8","key":"5214_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrurol.2010.101","volume":"7","author":"GR Nielubowicz","year":"2010","unstructured":"Nielubowicz GR, Mobley HL (2010) Host\u2013pathogen interactions in urinary tract infection. Nat Reviews Urol 7(8):430\u2013441","journal-title":"Nat Reviews Urol"},{"issue":"11","key":"5214_CR24","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00467-011-2089-1","volume":"27","author":"B Ragnarsd\u00f3ttir","year":"2012","unstructured":"Ragnarsd\u00f3ttir B, Svanborg C (2012) Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host\u2013pathogen interaction in urinary tract infections. Pediatr Nephrol 27(11):2017\u20132029","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"5214_CR25","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","volume":"19","author":"SG Reed","year":"2013","unstructured":"Reed SG, Orr MT, Fox CB (2013) Key roles of adjuvants in modern vaccines. Nat Med 19(12):1597\u20131608","journal-title":"Nat Med"},{"issue":"4","key":"5214_CR26","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/01.ju.0000116123.05160.43","volume":"171","author":"JA Roberts","year":"2004","unstructured":"Roberts JA, Kaack MB, Baskin G, Chapman MR, Hunstad DA, Pinkner JS et al (2004) Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J Urol 171(4):1682\u20131685","journal-title":"J Urol"},{"issue":"2","key":"5214_CR27","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1128\/IAI.74.2.1387-1393.2006","volume":"74","author":"JA Snyder","year":"2006","unstructured":"Snyder JA, Lloyd AL, Lockatell CV, Johnson DE, Mobley HL (2006) Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun 74(2):1387\u20131393","journal-title":"Infect Immun"},{"key":"5214_CR28","unstructured":"Tama RT, Hossain MS, Rahaman MA, Alam MA, Rahman M-M, Parvin A et al (2026) Health Sciences Review"},{"key":"5214_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1401462","volume":"14","author":"A Tantibhadrasapa","year":"2024","unstructured":"Tantibhadrasapa A, Li S, Buddhasiri S, Sukjoi C, Mongkolkarvin P, Boonpan P et al (2024) Probiotic Limosilactobacillus reuteri KUB-AC5 decreases urothelial cell invasion and enhances macrophage killing of uropathogenic Escherichia coli in vitro study. Front Cell Infect Microbiol 14:1401462","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"5214_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41579-024-01092-4","volume":"23","author":"MR Timm","year":"2025","unstructured":"Timm MR, Russell SK, Hultgren SJ (2025) Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol 23(2):72\u201386","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"5214_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1365-2958.2000.02165.x","volume":"38","author":"B Wullt","year":"2000","unstructured":"Wullt B, Bergsten G, Connell H, R\u00f6llano P, Gebretsadik N, Hull R et al (2000) P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 38(3):456\u2013464","journal-title":"Mol Microbiol"},{"issue":"13","key":"5214_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310537","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y et al (2023) Urinary tract infections caused by uropathogenic Escherichia coli: mechanisms of infection and treatment options. Int J Mol Sci 24(13):10537","journal-title":"Int J Mol Sci"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05214-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05214-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05214-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:48:51Z","timestamp":1789465731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-05214-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["5214"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05214-9","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments and protocols were reviewed and approved by the Ethics Committee of the Iranian Veterinary Organization (Approval Code: IR.IVO.REC.1400.341\n                      ).\n                      All procedures were performed in strict accordance with the relevant national and institutional guidelines and regulations for the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"631"}}